Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) EBIT: 2019-2024

Historic EBIT for IDEAYA Biosciences (IDYA) over the last 6 years, with Dec 2024 value amounting to -$327.0 million.

  • IDEAYA Biosciences' EBIT rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
  • As of FY2024, IDEAYA Biosciences' EBIT stood at -$327.0 million, which was down 143.23% from -$134.4 million recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' EBIT registered a high of -$35.3 million during FY2020, and its lowest value of -$327.0 million during FY2024.
  • Moreover, its 3-year median value for EBIT was -$134.4 million (2023), whereas its average is -$174.6 million.
  • Its EBIT has fluctuated over the past 5 years, first grew by 20.16% in 2020, then slumped by 143.23% in 2024.
  • Over the past 5 years, IDEAYA Biosciences' EBIT (Yearly) stood at -$35.3 million in 2020, then crashed by 42.22% to -$50.3 million in 2021, then decreased by 24.34% to -$62.5 million in 2022, then slumped by 115.08% to -$134.4 million in 2023, then plummeted by 143.23% to -$327.0 million in 2024.